| James Joyner Llc | |
|
1380 Lusitana St Ste 904 Honolulu HI 96813-2448 | |
| (808) 366-4886 | |
| Not Available |
| Full Name | James Joyner Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1380 Lusitana St Ste 904, Honolulu, Hawaii |
| Authorized Official Name and Position | James Joyner (PRESIDENT) |
| Authorized Official Contact | 8083664886 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| James Joyner Llc Po Box 25490 Honolulu HI 96825-0490 Ph: (808) 536-0300 | James Joyner Llc 1380 Lusitana St Ste 904 Honolulu HI 96813-2448 Ph: (808) 366-4886 |
| NPI Number | 1164602330 |
|---|---|
| Provider Enumeration Date | 11/05/2007 |
| Last Update Date | 11/05/2007 |
| Medicare PECOS PAC ID | 5395833404 |
|---|---|
| Medicare Enrollment ID | O20071126000481 |
News Archive
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for its initial lead candidate, TOL101, for prophylaxis of acute rejection of solid organ transplantation.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
A new understanding of insulin resistance and the action of diabetes drugs such as Avandia and Actos could pave the way for improved medications that are more selective and safer, say scientists from Dana-Farber Cancer Institute and The Scripps Research Institute.Our findings strongly suggest that good and bad effects of these drugs can be separated by designing second-generation drugs that focus on the newly uncovered mechanism, said Bruce Spiegelman, PhD, of Dana-Farber, senior author on a report appearing in the July 22 issue of Nature.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164602330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 13962 (Hawaii) | Primary |
| Provider Name | James L Joyner |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1184704355 PECOS PAC ID: 2163403387 Enrollment ID: I20070605000188 |
News Archive
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for its initial lead candidate, TOL101, for prophylaxis of acute rejection of solid organ transplantation.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
A new understanding of insulin resistance and the action of diabetes drugs such as Avandia and Actos could pave the way for improved medications that are more selective and safer, say scientists from Dana-Farber Cancer Institute and The Scripps Research Institute.Our findings strongly suggest that good and bad effects of these drugs can be separated by designing second-generation drugs that focus on the newly uncovered mechanism, said Bruce Spiegelman, PhD, of Dana-Farber, senior author on a report appearing in the July 22 issue of Nature.
› Verified 4 days ago
News Archive
Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for its initial lead candidate, TOL101, for prophylaxis of acute rejection of solid organ transplantation.
A study from Karolinska Institutet in Sweden shows that a new drug for Huntington's disease - pridopidine or dopamine stabiliser ACR16 - might operate via previously unknown mechanisms of action. Researchers have found that at very low concentrations, ACR16 binds to the sigma-1 receptor, a protein in the brain important to neuronal function and survival.
A new understanding of insulin resistance and the action of diabetes drugs such as Avandia and Actos could pave the way for improved medications that are more selective and safer, say scientists from Dana-Farber Cancer Institute and The Scripps Research Institute.Our findings strongly suggest that good and bad effects of these drugs can be separated by designing second-generation drugs that focus on the newly uncovered mechanism, said Bruce Spiegelman, PhD, of Dana-Farber, senior author on a report appearing in the July 22 issue of Nature.
› Verified 4 days ago
Sbk Medical Consulting Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1441 Kapiolani Blvd Ste 606, Honolulu, HI 96814 Phone: 808-951-9931 | |
Emily Diep, M.d., Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 321 N Kuakini St, Suite Number 715, Honolulu, HI 96817 Phone: 808-523-6461 Fax: 808-550-0466 | |
Restoration Health Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 828 18th Ave, Honolulu, HI 96816 Phone: 808-892-7571 | |
Central Medical Clinic Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 321 N. Kuakini St., Suite #201, Honolulu, HI 96817 Phone: 808-523-8611 | |
Frederick Fong Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1380 Lustiana Street, Suite 514, Honolulu, HI 96813 Phone: 808-531-7551 Fax: 808-537-3652 | |
Dr Jin Kim Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2851 E Manoa Rd Ste 1-205, Honolulu, HI 96822 Phone: 808-988-6113 | |
Mahalo Doctor Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 415-314-0699 |